![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 1, 322-327, January 7, 2000
From the Activation of the stress-activated protein kinase
(SAPK/JNK) by genotoxic agents is necessary for induction of apoptosis. We report here that ionizing radiation ionizing radiation exposure induces translocation of SAPK to mitochondria and association of SAPK
with the anti-apoptotic Bcl-xL protein. SAPK
phosphorylates Bcl-xL on threonine 47 (Thr-47) and
threonine 115 (Thr-115) in vitro and in vivo.
In contrast to wild-type Bcl-xL, a mutant
Bcl-xL with the two threonines substituted by alanines
(Ala-47, Ala-115) is a more potent inhibitor of ionizing
radiation-induced apoptosis. These findings indicate that translocation
of SAPK to mitochondria is functionally important for interactions with
Bcl-xL in the apoptotic response to genotoxic stress.
The cellular response to ionizing radiation
(IR)1 and other genotoxic
agents includes cell cycle arrest, activation of DNA repair and
apoptosis, or physiological cell death. However, the intracellular
signals that control these events are unclear. The available evidence
indicates that IR induces these effects by direct interaction with DNA
or through formation of reactive oxygen intermediates, which damage DNA
and cell membranes (1). Whereas p53 has been shown to be involved in
promoting apoptosis induced by IR exposure (2, 3), other studies have
demonstrated that Bcl-2 and Bcl-xL inhibit IR-induced
apoptosis (4-6). The induction of apoptosis is associated with
activation of aspartate-specific cysteine proteases (caspases) and
cleavage of poly(ADP-ribose) polymerase, protein kinase C The stress-activated protein kinases (SAPKs), also known as c-Jun
amino-terminal kinases (JNKs) and p38 MAP kinase, are activated in
response to diverse stimuli including DNA damage, heat shock, interleukin-1, tumor necrosis factor The present studies demonstrate that exposure of U-937 cells to IR is
associated with translocation of active SAPK to mitochondria and its
association with the anti-apoptotic protein Bcl-xL. The results also demonstrate that SAPK phosphorylates Bcl-xL on
threonines 47 and 115, and overexpression of mutant Bcl-xL
(A-47, A-115) causes a more potent inhibition of IR-induced apoptosis.
Cell Culture and Reagents--
Human U-937,
U-937/Bcl-xL, and U-937/Bcl-xL(A-47,-115)
myeloid leukemia cells were grown in RPMI 1640 medium supplemented with
10% heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine.
Rat-1/myc, Rat-1/myc/Bcl-xL, and
Rat-1/myc/Bcl-xL(A-47,-115) cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal
bovine serum and antibiotics. IR was performed with a Immunofluorescence Microscopy--
Control and IR-treated U-937
cells immobilized on slides were fixed (3.7% formaldehyde),
permeabilized (0.2% Triton X-100), and incubated with 20 ng/slide of
anti-SAPK polyclonal antibody (Santa Cruz Biotechnology), followed by
Texas Red-conjugated goat anti-rabbit IgG (Southern Biotechnology
Associates, Inc.). Mitochondria were stained with 0.006 ng/slide of
Mitotracker Green FM (Molecular Probes). Nuclei were stained with
4,6-diamidino-2-phenylindole (1 µg/ml in phosphate-buffered saline).
The slides were analyzed using a Zeiss Auxiphot fluorescence microscope
coupled to a CCD camera and a Power Macintosh 8100. Image analysis was
performed using the IPLab Spectrum 3.1 software (Signal Analytics).
Isolation of Cytoplasmic and Mitochondrial Fractions--
Cells
were washed twice with phosphate-buffered saline, and cell
fractionation was performed as described (30).
Immunoprecipitation and Immunoblot
Analysis--
Immunoprecipitation was performed as described (33). In
brief, soluble proteins were incubated with anti-SAPK (Santa Cruz) antibody for 1 h and precipitated with protein A-Sepharose for an
additional 30 min. The resulting immune complexes were analyzed by
immunoblotting with anti-Bcl-x antibodies (34). U-937/Bcl-xL cells were
exposed to 20 Gy IR and harvested after 1 h. Total cell lysates
were subjected to immunoprecipitation with anti-Bcl-xL, and the
precipitates were analyzed by immunoblotting with anti-Bax (Santa Cruz) antibody.
Far Western Analysis--
Column-purified
H6-Bcl-xLT, Bcl-xST, or
H6 proteins were resolved by SDS-PAGE and transferred to a
nitrocellulose filter. The filters were incubated with purified
GST-SAPK for 1 h, and immunoblot analysis was performed as
described (30). Purified SAPK and H6-SHPTP1 proteins were
resolved by SDS-PAGE and transferred to nitrocellulose filters. The
filters were incubated with H6-Bcl-xL or
H6 proteins and analyzed by immunoblotting with
anti-Bcl-xL antibody.
Immune Complex Kinase Assays--
GST-SAPK or anti-SAPK
immunoprecipitates from cells were incubated with
H6-Bcl-xLT, Bcl-xST,
H6-Bcl-xLT(A-47,-115), or GST-Jun (35), and
in vitro immune complex kinase assays were performed as
described (15).
Phosphopeptide Mapping and Phosphoamino Acid
Analysis--
32P-Labeled Bcl-xLT recovered
from unfixed dried SDS-polyacrylamide gels by homogenizing gel slices
in the presence of trichloroacetic acid was oxidized with performic
acid, resuspended in 25 µl of 50 mM
NH4HC03, and digested overnight at 37 °C
with 10 µg of tosylphenylalanyl chloromethyl ketone-treated trypsin
(36). After digestion, samples were repeatedly lyophilized. Tryptic
digests of the phosphorylated Bcl-xLT were subjected to
electrophoresis using pH 1.9 buffer (15% acetic acid, 5% formic acid)
followed by ascending chromatography with Scheidtmann buffer
(isobutyric acid:pyridine:acetic acid:butanol:water (65:5:3:2:29)) as
described (37). Phosphopeptides were visualized by autoradiography.
Individual spots were scraped from the cellulose plates, and
phosphopeptides were eluted with pH 1.9 buffer. After lyophilization,
phosphopeptides were subjected to partial acid hydrolysis, and
hydrolized products were subjected to two-dimensional electrophoresis.
Phosphorylation of Bcl-xL by SAPK in Vivo--
293T
cells were transiently cotransfected with HA-Bcl-xL and
MEKK-1 or MEKK-1 K-N by LipofectAMINE (Life Technologies, Inc.). At
36 h after transfection, cells were labeled with
[32P]orthophosphate (0.5 mCi/ml) in a phosphate-free
media for 3 h. Total cell lysates were then subjected to
immunoprecipitation with anti-HA antibody. Immunopurified labeled
HA-Bcl-xL under conditions of active or inactive MEKK-1 were separated
by SDS-PAGE and analyzed by autoradiography. Anti-HA immunoprecipitates
were also analyzed by immunoblotting with anti-HA. As a control, total cell lysates from transfected but unlabeled 293T cells were subjected to immunoprecipitation with anti-SAPK, and in vitro immune
complex kinase assays were performed using GST-Jun as substrate as
described above.
Generation of Bcl-xL and Bcl-xLT
Mutants--
Mutations in full-length (Bcl-xL) or
truncated (Bcl-xLT) and generation of various plasmids
(HA-Bcl-xL) were performed as described (30).
Cell Survival and Apoptosis Assays--
U-937,
U-937/Bcl-xL, or U-937/Bcl-xL(A-47,-115) cells
were treated with 20 Gy IR and harvested at the indicated times.
Terminal deoxynucleotidyltransferase-mediated UTP end-labeling (TUNEL) assays were performed as described (38). Numbers of cells with sub-G1 DNA content were determined with a ModFit LT program
(Verity Software House) (38). Rat-1/myc, Rat-1/myc/Bcl-xL,
or Rat-1/myc/Bcl-xL(A-47,-115) cells were treated with
bleomycin. After 3 days, apoptotic cells were determined using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays as
described (39, 40).
The stress-activated protein kinase (SAPK/JNK) is induced by IR
and other genotoxic agents (13, 14, 16, 41-43). Other studies support
a role for SAPK in induction of apoptosis (23, 24). Translocation of
activated SAPK to the nucleus has been found in hypoxic cells and after
treatment with ultraviolet radiation (44, 45). Here we investigated
subcellular localization of SAPK in response to genotoxic stress by
measuring intracellular fluorescence with a high sensitivity CCD camera
and image analyzer. Examination of the distribution of fluorescence
markers in control U-937 cells showed distinct patterns for anti-SAPK
(red signal) and a mitochondrion-selective dye (Mitotracker;
green signal) (Fig.
1A). By contrast, exposure to
IR was associated with a dramatic change in fluorescence signals
(red and green Bcl-xL is predominantly a mitochondrial protein (29, 46).
To determine if SAPK associates with Bcl-xL following
translocation to mitochondria, we studied co-localization of these
proteins using immunofluorescence microscopy. In unirradiated cells,
staining patterns of SAPK (green signal) and
Bcl-xL (red signal) were mainly distinct (Fig.
2A). Importantly, IR exposure
was associated with apparent co-localization of these proteins, as
evident from the marked changes of fluorescence signals to
yellow/orange (Fig. 2A). To determine
biochemically whether SAPK forms a complex with Bcl-xL, we
subjected anti-SAPK immunoprecipitates to immunoblotting with
anti-Bcl-x. Cytoplasmic fractions from control and irradiated cells
demonstrated little if any association of SAPK and Bcl-xL (Fig. 2B); however, a similar analysis of the mitochondrial
fraction demonstrated that IR induces binding of SAPK to
Bcl-xL (Fig. 2B). To address whether
Bcl-xL interacts directly with SAPK, we prepared a
truncated His-tagged Bcl-xL protein lacking 21 amino acids
from the carboxyl terminus to avoid aggregation and precipitation in in vitro reactions (H6-Bcl-xLT)
(30). GST-SAPK fusion protein was resolved by gel electrophoresis and
transferred to a nitrocellulose filter. Two identical filters were
prepared. Filters were separately incubated either with
H6-Bcl-xL or H6 proteins and analyzed by immunoblotting with anti-Bcl-xL. As a control, purified
H6-SHPTP1 protein was also resolved by SDS-PAGE and
transferred to nitrocellulose filters. After incubation with
H6-Bcl-xLT, the filters were probed with
anti-Bcl-xL. By contrast to SHPTP1, reactivity of
anti-Bcl-xL at the position corresponding to GST-SAPK
(~80 kDa) indicated direct interaction between Bcl-xL and
SAPK (Fig. 2C). In the reciprocal experiment,
Bcl-xLT and Bcl-xST were resolved by gel
electrophoresis and transferred to filters. After incubation with
recombinant GST-SAPK, the filters were probed with anti-SAPK. The
results confirmed direct binding of SAPK to Bcl-xL and
not Bcl-xS (Fig. 2D).
Translocation of SAPK/JNK to Mitochondria and Interaction with
Bcl-xL in Response to DNA Damage*
§¶,
,
,
,
,
,
,
,
,
,
Division of Cancer Pharmacology, Dana-Farber
Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115,
Manitoba Institute of Cell Biology, University of Manitoba,
Winnipeg, Manitoba R3EOV9, Canada, ** Oncology Research Program,
Preclinical Research, Novartis Pharmaceuticals Corp., East Hanover,
New Jersey 07936, and 
Department of Radiation and Cellular
Oncology, University of Chicago, Chicago, Illinois 60637
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
, and other
proteins (7-9). The demonstration that cleavage of poly(ADP-ribose)
polymerase and protein kinase C
is blocked by Bcl-xL has
suggested that the Bcl-2-related family of anti-apoptotic proteins
functions upstream to the activation of caspases (9-11).
, and Fas (12-22). Recent studies have shown that activation of c-Abl by exposure to IR contributes to the induction of Jun kinase and p38 MAPK (14, 15, 22).
Activation of SAPK and p38 MAPK pathways has been associated with
induction of apoptosis (23-25). However, the mechanisms involved in
SAPK/JNK-induced apoptosis are presently unclear. Recent studies have
demonstrated that mitochondria play a central role in inducing
apoptosis by releasing cytochrome c (26, 27). The
demonstration that the anti-apoptotic Bcl-2 family of proteins is
expressed in the mitochondrial membrane has also implicated mitochondria in the induction apoptosis (28, 29). Importantly, we and
others have shown that overexpression of Bcl-2 or the related Bcl-xL blocks the release of cytochrome c from
mitochondria, which otherwise occurs when cells are signaled to undergo
apoptosis (30-32).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-ray source
(Cs 173, Gamma Cell 1000, Atomic Energy of Canada, Ontario) at a fixed
dose rate of 13 Gy/min. Cells were also treated with bleomycin (Sigma).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
yellow/orange), supporting translocation of SAPK
to mitochondria (Fig. 1A). To confirm these findings,
cytoplasmic and mitochondrial fractions were subjected to
immunoblotting with anti-SAPK. Consistent with the immunofluorescence
data, IR exposure induced translocation of SAPK to mitochondria (Fig.
1B). Purity of the mitochondrial and cytoplasmic fractions
was confirmed by reprobing the blots with an antibody against the
mitochondrial-specific HSP60 protein (Fig. 1B). These
findings demonstrate that IR induces SAPK to translocate to
mitochondria.

View larger version (49K):
[in a new window]
Fig. 1.
Translocation of SAPK to mitochondria in
response to IR. A, U-937 cells were treated with 20 Gy
IR and harvested after 1 h. After washing, cells were immobilized
on slides, fixed, and incubated with anti-SAPK (Santa Cruz) antibody
followed by Texas Red-conjugated goat anti-rabbit IgG. Mitochondria
were stained with the mitochondria-selective permeant dye Mitotracker
Green FM. Nuclei were stained with 4,6-diamidino-2-phenylindole. The
slides were visualized using a Zeiss Auxiphot fluoresence microscope
coupled to a high sensitivity CCD camera and image analyzer. Red
signal, SAPK; green signal, Mitotracker;
yellow/orange signal, co-localization of SAPK and
mitochondria signals. B, U-937 cells were treated with 20 Gy
IR and harvested at 1 h. Cytoplasmic (Cyto) and
mitochondrial (Mito) fractions (34) were isolated and
subjected to immunoblotting with anti-SAPK or anti-HSP60 (Sigma)
antibodies.

View larger version (26K):
[in a new window]
Fig. 2.
Association of SAPK with
Bcl-xL. A, U-937 cells were treated with 20 Gy IR and harvested after 1 h. Cells were incubated with anti-SAPK
and anti-Bcl-xL followed by fluorescein
isothiocyanate-conjugated donkey anti-goat IgG and Texas Red-conjugated
goat anti-rabbit IgG antibodies. Red signal,
Bcl-xL; green signal, SAPK;
yellow/orange signal, co-localization of
Bcl-xL and SAPK. top panels, 100×; bottom
panels, 40×. B, U-937 cells were exposed to 20 Gy IR
and harvested after 1 h. Cytoplasmic (Cyto) and
mitochondrial (Mito) lysates from control, and IR-treated
U-937 cells were subjected to immunoprecipitation (IP) with
anti-SAPK antibodies. The proteins were separated by 10% SDS-PAGE and
analyzed by immunoblotting (IB) with anti-Bcl-xL
antibodies. Mitochondrial lysate from U-937/Bcl-xL cells
was used as a positive (+ve) control. C,
recombinant purified GST-SAPK protein was subjected to 10% SDS-PAGE
and transferred to nitrocellulose filters (left panel).
H6-SHPTP1 (SHPTP) protein was included as a
control (right panel). The filters were incubated with
H6-Bcl-xLT or H6 proteins and
analyzed by immunoblotting with anti-Bcl-xL antibodies.
D, nickel-purified H6-Bcl-xLT,
H6, or GST-Bcl-xST proteins were separated by
12.5% SDS-PAGE and transferred to nitrocellulose. The filters were
then incubated with purified recombinant GST-SAPK protein and analyzed
by immunoblotting with anti-SAPK.
SAPK phosphorylates c-Jun in response to genotoxic stress. To determine
whether Bcl-xLT is also a substrate for SAPK
phosphorylation, recombinant H6-Bcl-xLT was
incubated with GST-SAPK in the presence of [
-32P]ATP.
Analysis of the reaction products demonstrated that, like GST-Jun, SAPK
phosphorylates H6-Bcl-xLT (Fig.
3A). Previous studies have
shown that SAPK binds and phosphorylates c-Jun (47, 48). In addition,
deletion of the SAPK-binding site in c-Jun is associated with a marked
decrease in SAPK-mediated phosphorylation of c-Jun (12). In concert
with the absence of SAPK binding to Bcl-xS, there was
little if any phosphorylation of GST-Bcl-xST by SAPK (Fig.
3A). As SAPK preferentially phosphorylates serine and/or threonine residues that are followed by prolines, we asked if the two
Thr-Pro (amino acids 47, 48 and 115, 116) and/or one Ser-Pro (amino
acids 62, 63) sites in Bcl-xL are phosphorylated by SAPK. Phosphopeptide mapping studies of Bcl-xL phosphorylated by
SAPK demonstrated the presence of two 32P-labeled peptides
(Fig. 3B). Phosphoamino acid analysis of these peptides
revealed phosphorylation on Thr residues (Fig. 3B). These studies identified Thr-47 and Thr-115 as SAPK phosphorylation sites.
Accordingly, there was no detectable SAPK-mediated phosphorylation of a
Bcl-xLT mutant in which these sites had been mutated to
alanines (Ala-47,Ala-115) (Fig. 3C).
|
To determine whether SAPK phosphorylates Bcl-xL in
vivo, 293T cells were transiently cotransfected with
HA-Bcl-xL and MEKK-1 (49) (an upstream regulator of SAPK
activity) (12, 50, 51) or the kinase-inactive MEKK-1 K-N mutant. Cells
were labeled with [32P]orthophosphate for 3 h. After
transfection and labeling, total cell lysates were subjected to
immunoprecipitation with anti-HA, and the precipitates were analyzed by
autoradiography. The results demonstrate that, in contrast to MEKK-1,
phosphorylation of Bcl-xL is significantly inhibited in
cells that overexpress MEKK-1 K-N (Fig.
4A). As a control, in
vitro SAPK immune complex kinase assays were performed using
GST-Jun as substrate. The results demonstrate that, in concert with the
previous findings (12, 50, 51), overexpression of MEKK-1, but not
MEKK-1 K-N, is associated with activation of SAPK (Fig. 4B
and data not shown). Taken together, these findings indicated that SAPK
phosphorylates Bcl-xL both in vitro and in
vivo.
|
Since activation of SAPK contributes to induction of apoptosis (23,
24), we asked if the Bcl-xL(A-47,-115) mutant is functional in regulating the apoptotic response. Sub-G1 DNA content in
propidium iodide-stained cells was assessed as a measure of apoptosis.
Although exposure of U-937 cells to IR increased the proportion of
cells with sub-G1 DNA, expression of the
Bcl-xL(A-47,-115) mutant resulted in a smaller
sub-G1 peak and increased resistance to apoptosis compared
with that in U-937 cells expressing wild-type Bcl-xL (Fig.
5A). To extend these findings,
we used Rat-1 cells transformed with c-myc (Rat-1/myc) that
respond to genotoxic stress with induction of apoptosis (46).
Overexpression of wild-type Bcl-xL blocked bleomycin-induced cell death of Rat-1/myc cells (Fig. 5B).
Significantly, overexpression of the Bcl-xL(A-47,-115)
mutant was more effective than Bcl-xL in blocking induction
of apoptosis (Fig. 5B). Similar results were obtained in
four independently selected Rat-1/myc clones that express
Bcl-xL(A-47,-115) (Fig. 5B). Thus, interaction between SAPK and Bcl-xL is functionally important in
induction of apoptosis in different cell types treated with diverse
genotoxic agents.
|
Previous studies have shown that Bcl-xL heterodimerizes with Bax (52). Other studies have demonstrated that Bad selectively forms heterodimers with Bcl-xL (53). When Bad heterodimerizes with Bcl-xL in mammalian cells, it displaces Bax from Bcl-xL and promotes cell death (53). To determine whether phosphorylation of Bcl-xL by SAPK affects the interaction of Bax with Bcl-xL, U-937 cells overexpressing Bcl-xL were exposed with IR, and total cell lysates were subjected to immunoprecipitation with anti-Bcl-xL. The protein precipitates were then analyzed by immunoblotting with anti-Bax. The results demonstrate that SAPK-mediated phosphorylation of Bcl-xL has no detectable effect on its association with Bax (data not shown).
SAPK is activated by genotoxic stress (13, 14, 16, 41-43) and
functions upstream to induction of apoptosis in response to DNA damage
(23, 24). The present work demonstrates for the first time that
genotoxic stress induces translocation of SAPK to mitochondria. Recent
studies have supported the release of cytochrome C from mitochondria to
the cytosol in the apoptotic response to DNA damage (30). However, the
initial signal that triggers mitochondrial changes in response to
apoptotic stimuli is presently not known. The findings that Bcl-2 and
Bcl-xL block release of cytochrome C and activation of
caspases has further supported the importance of mitochondria in
induction of apoptosis (30-32). In this context, our finding that SAPK
associates with Bcl-xL in mitochondria provides a potential
link between mitochondrial translocation of SAPK and apoptosis. The
results demonstrate that SAPK phosphorylates Bcl-xL at
Thr-Pro sites. Thr-47 resides in a 60-residue loop that is nonessential
for anti-apoptotic activity (54, 55), whereas Thr-115 is adjacent to
the
3 helix, which may be important structurally for formation of
ion channels. The Bcl-xL(A-47,-115) mutant was more
effective than wild-type Bcl-xL in blocking apoptosis.
Thus, the Bcl-xL mutant may, as a defective substrate,
promote formation of stable SAPK complexes that would otherwise
dissociate after phosphorylation of wild-type Bcl-xL. In
this regard, our results demonstrate that the Thr to Ala mutant of
Bcl-xL associates with SAPK with higher affinity than that obtained with wild-type Bcl-xL (data not shown). Whereas
SAPK activation is necessary for induction of apoptosis (23, 24), sequestration of SAPK in mitochondria by Bcl-xL(A-47,-115)
could abrogate other functions of SAPK, particularly in the cytoplasm or nucleus, that are required for the apoptotic response.
| |
ACKNOWLEDGEMENTS |
|---|
We thank J. Kyriakis and L. Zon for various SAPK cDNA constructs, L. Boise and C. Thompson for anti-Bcl-x antibodies, and Andrew Place, Atsuko Nakazawa, and Xiangquo Qui for technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants CA 75216 (to S. K.) and CA55421 (to D. K.) and by a Medical Research Council of Canada Grant MT-14361 (to S. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Dept. of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney St., Boston, MA 02115. Tel.: 617-632-2938; Fax: 617-632-2934; E-mail: surender_kharbanda@dfci.harvard.edu.
¶ These authors contributed equally.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IR, ionizing radiation; SAPK, stress-activated protein kinase; JNK, c-Jun N-terminal protein kinase; MAPK, mitogen-activated protein kinase; Bcl-2, B-cell lymphoma protein-2; PAGE, polyacrylamide gel electrophoresis; MEKK-1, mitogen/extracellular-regulated kinase kinase-1; Gy, gray; GST, glutathione S-transferase; HA, hemagglutinin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hall, E. J. (1988) Radiobiology for the Radiologist , pp. 128-135, Lippincott-Raven Publishers, Philadelphia |
| 2. | Lowe, S. W., Schmitt, E., Smith, S., Osborne, B., and Jacks, T. (1993) Nature 362, 847-849[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wylie, A. H. (1993) Nature 362, 849-852[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S. J. (1991) Cell 67, 879-888[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Strasser, A., Harris, A., and Cory, S. (1991) Cell 67, 889-899[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Datta, R., Manome, Y., Taneja, N., Boise, L. H., Weichselbaum, R. R., Thompson, C. B., Slapak, C. A., and Kufe, D. W. (1995) Cell Growth Differ. 6, 363-370[Abstract] |
| 7. | Martin, S. J., and Green, D. R. (1995) Cell 82, 349-352[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Kaufmann, S. H.,
Desnoyers, S.,
Ottaviano, Y.,
Davidson, N. E.,
and Poirier, G. G.
(1993)
Cancer Res.
53,
3976-3985 |
| 9. | Emoto, Y., Manome, G., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., Weichselbaum, R., and Kufe, D. (1995) EMBO J. 14, 6148-6156[Medline] [Order article via Infotrieve] |
| 10. |
Chinnaiyan, A. M.,
Orth, K.,
O'Rourke, K.,
Duan, H.,
Poirier, G. G.,
and Dixit, V. M.
(1996)
J. Biol. Chem.
271,
4573-4576 |
| 11. |
Datta, R.,
Kojima, H.,
Banach, D.,
Bump, N.,
Talanian, R.,
Alnemri, E.,
Weichselbaum, R.,
Wong, W.,
and Kufe, D.
(1996)
J. Biol. Chem.
272,
1965-1969 |
| 12. | Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Kharbanda, S.,
Saleem, A.,
Shafman, T.,
Emoto, Y.,
Taneja, N.,
Rubin, E.,
Weichselbaum, R.,
Woodgett, J.,
Avruch, J.,
Kyriakis, J.,
and Kufe, D.
(1995)
J. Biol. Chem.
270,
18871-18874 |
| 14. | Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. W. (1995) Nature 376, 785-788[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Kharbanda, S.,
Pandey, P.,
Ren, R.,
Mayer, B.,
Zon, L.,
and Kufe, D.
(1995)
J. Biol. Chem.
270,
30278-30281 |
| 16. |
Chen, Y.-R.,
Meyer, C. F.,
and Tan, T. H.
(1996)
J. Biol. Chem.
271,
631-634 |
| 17. | Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994) Nature 369, 156-160[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Lee, J. C., Laydon, J. T., McConnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W., Strikler, J. E., McLaughlin, M. M., Siemens, I. R., Fisher, S. M., Livi, G. P., White, J. R., Adams, J. L., and Young, P. R. (1994) Nature 372, 739-746[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Sluss, H.,
Barett, T.,
Derijard, B.,
and Davis, R. J.
(1994)
Mol. Cell. Biol.
14,
8376-8384 |
| 20. |
Han, J.,
Lee, J.-D.,
Bibbs, L.,
and Ulevitch, R. J.
(1994)
Science
265,
808-811 |
| 21. |
Gupta, S.,
Campbell, D.,
Dérijard, B.,
and Davis, R. J.
(1995)
Science
267,
389-393 |
| 22. |
Pandey, P.,
Raingeaud, J.,
Kaneki, M.,
Weichselbaum, R.,
Davis, R.,
Kufe, D.,
and Kharbanda, S.
(1996)
J. Biol. Chem.
271,
23775-23779 |
| 23. | Verheij, M., Bose, R., Lin, X. H., Yhao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. (1996) Nature 380, 75-79[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Xia, Z.,
Dickens, M.,
Raingeaud, J.,
Davis, R. J.,
and Greenberg, M. E.
(1995)
Science
270,
1326-1331 |
| 25. |
Johnson, N. L.,
Gardner, A. M.,
Diener, K. M.,
Lange-Carter, C. A.,
Gleavy, J.,
Jarpe, M. B.,
Minden, A.,
Karin, M.,
Zon, L. I.,
and Johnson, G. L.
(1996)
J. Biol. Chem.
271,
3229-3237 |
| 26. | Liu, X., Naekyung Kim, C., Yang, J., Jemmerson, R., and Wang, X. (1996) Cell 86, 147-157[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. (1997) Cell 90, 405-413[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Zamzami, N.,
Marchetti, P.,
Castedo, M.,
Decaudin, D.,
Macho, A.,
Hirsch, T.,
Susin, S. A.,
Petit, P. X.,
Mignotte, B.,
and Kroemer, G.
(1995)
J. Exp. Med.
182,
367-377 |
| 29. |
Zamzami, N.,
Marchetti, P.,
Castedo, M.,
Zanin, C.,
Vayssiere, J. L.,
Petit, P. X.,
and Kroemer, G.
(1995)
J. Exp. Med.
181,
1661-1672 |
| 30. |
Kharbanda, S.,
Pandey, P.,
Schofield, L.,
Roncinske, R.,
Bharti, A.,
Yuan, Z.-M.,
Weichselbaum, R.,
Nalin, C.,
and Kufe, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
6939-6942 |
| 31. |
Yang, J.,
Liu, X.,
Bhalla, K.,
Kaekyung Kim, C.,
Ibrado, A. M.,
Cai, J.,
Peng, T.-I.,
Jones, D. P.,
and Wang, X.
(1997)
Science
275,
1129-1132 |
| 32. |
Kluck, R. M.,
Bossy-Wetzel, E.,
Green, D. R.,
and Newmeyer, D. D.
(1997)
Science
275,
1132-1136 |
| 33. |
Kharbanda, S.,
Yuan, Z. M.,
Rubin, E.,
Weichselbaum, R.,
and Kufe, D.
(1994)
J. Biol. Chem.
269,
20739-20743 |
| 34. | Boise, L. H., Gonzaiz-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. (1993) Cell 74, 597-608[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Saleem, A., Yuan, Z. M., Taneja, N., Rubin, E., Kufe, D. W., and Kharbanda, S. (1995) J. Immunol. 154, 4150-4156[Abstract] |
| 36. | Boyle, W. J., van der Geer, P., and Hunter, T. (1991) Methods Enzymol. 201, 110-149[Medline] [Order article via Infotrieve] |
| 37. |
Scheidtmann, K. H.,
Echle, B.,
and Walter, G.
(1982)
J. Virol.
44,
116-133 |
| 38. |
Yuan, Z.-M.,
Huang, Y.,
Ishiko, T.,
Kharbanda, S.,
Weichselbaum, R.,
and Kufe, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1437-1440 |
| 39. | Cory, A. H., Owen, T. C., Barltrop, J. A., and Cory, J. G. (1991) Cancer Commun. 3, 207-211[Medline] [Order article via Infotrieve] |
| 40. | Yu, K., Ravera, C. P., Chen, Y. N., and McMahon, G. (1997) Cell Growth Differ. 8, 731-742[Abstract] |
| 41. | Saleem, A., Datta, R., Kharbanda, S., and Kufe, D. (1995) Cell Growth Differ. 6, 1651-1658[Abstract] |
| 42. |
Chen, Y.-R.,
Wang, X.,
Templeton, D.,
Davis, R. J.,
and Tan, T.-H.
(1996)
J. Biol. Chem.
271,
31929-31936 |
| 43. | Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F.-F., and Woodgett, J. R. (1996) Curr. Biol. 6, 606-613[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Kawasaki, H., Moriguchi, T., Matsuda, S., Li, H. Z., Nakamura, S., Shimohama, S., Kimura, J., Gotoh, Y., and Nishida, E. (1996) Eur. J. Biochem. 241, 315-321[Medline] [Order article via Infotrieve] |
| 45. |
Mizukami, Y.,
Yoshioka, K.,
Morimoto, S.,
and Yoshida, K.
(1997)
J. Biol. Chem.
272,
16657-16662 |
| 46. | Gonsalez-Garcia, M., Perez-Ballestero, R., Ding, L., Duan, L., Boise, L. H., Thompson, C. B., and Nunuz, G. (1994) Development 120, 3033-3042[Abstract] |
| 47. | Woodgett, J. R., Avruch, J., and Kyriakis, J. (1996) Cancer Surv. 27, 127-138[Medline] [Order article via Infotrieve] |
| 48. | Davis, R. J. (1994) Trends Biochem. Sci. 19, 470-473[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., and Johnson, G. L. (1993) Science 260, 325-319 |
| 50. |
Minden, A.,
Lin, A.,
McMohan, M.,
Lange-Carter, C.,
Derijard, B.,
Davis, R. J.,
Johnson, G. L.,
and Karin, M.
(1994)
Science
266,
1719-1723 |
| 51. | Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., and Templeton, D. J. (1994) Nature 372, 798-800[Medline] [Order article via Infotrieve] |
| 52. | Oltavi, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) Cell 74, 609-619[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995) Cell 80, 285-291[CrossRef][Medline] [Order article via Infotrieve] |
| 54. | Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., Ng, S.-C., and Fesik, S. W. (1996) Nature 381, 335-341[CrossRef][Medline] [Order article via Infotrieve] |
| 55. | Minn, A. J., Velez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M., and Thompson, C. B. (1997) Nature 385, 353-357[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
B. Saberi, M. Shinohara, M. D. Ybanez, N. Hanawa, W. A. Gaarde, N. Kaplowitz, and D. Han Regulation of H2O2-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes Am J Physiol Cell Physiol, July 1, 2008; 295(1): C50 - C63. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hanawa, M. Shinohara, B. Saberi, W. A. Gaarde, D. Han, and N. Kaplowitz Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury J. Biol. Chem., May 16, 2008; 283(20): 13565 - 13577. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, M. Rzhetskaya, T. Kareva, R. Bland, M. J. During, A. W. Tank, N. Kholodilov, and R. E. Burke Antiapoptotic and Trophic Effects of Dominant-Negative Forms of Dual Leucine Zipper Kinase in Dopamine Neurons of the Substantia Nigra In Vivo J. Neurosci., January 16, 2008; 28(3): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kauskot, F. Adam, A. Mazharian, N. Ajzenberg, E. Berrou, A. Bonnefoy, J.-P. Rosa, M. F. Hoylaerts, and M. Bryckaert Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation J. Biol. Chem., November 2, 2007; 282(44): 31990 - 31999. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, P. Zhou, L. Qian, J.-Z. Chuang, J. Lee, C. Li, C. Iadecola, C. Nathan, and A. Ding MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival J. Exp. Med., September 3, 2007; 204(9): 2063 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Malhi, F. J Barreyro, H. Isomoto, S. F Bronk, and G. J Gores Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity Gut, August 1, 2007; 56(8): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Autret, S. Martin-Latil, L. Mousson, A. Wirotius, F. Petit, D. Arnoult, F. Colbere-Garapin, J. Estaquier, and B. Blondel Poliovirus Induces Bax-Dependent Cell Death Mediated by c-Jun NH2-Terminal Kinase J. Virol., July 15, 2007; 81(14): 7504 - 7516. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Tran, P. Andreka, C. O. Rodrigues, K. A. Webster, and N. H. Bishopric Jun Kinase Delays Caspase-9 Activation by Interaction with the Apoptosome J. Biol. Chem., July 13, 2007; 282(28): 20340 - 20350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lee and M. Jung The Nucleoside Analog Sangivamycin Induces Apoptotic Cell Death in Breast Carcinoma MCF7/Adriamycin-resistant Cells via Protein Kinase C{delta} and JNK Activation J. Biol. Chem., May 18, 2007; 282(20): 15271 - 15283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wilhelm, Z. Xu, N. V. Kukekov, S. Gire, and L. A. Greene Proapoptotic Nix Activates the JNK Pathway by Interacting with POSH and Mediates Death in a Parkinson Disease Model J. Biol. Chem., January 12, 2007; 282(2): 1288 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lopez-Sanchez, J.-R. Rodriguez, and J. M. Frade Mitochondrial c-Jun NH2-Terminal Kinase Prevents the Accumulation of Reactive Oxygen Species and Reduces Necrotic Damage in Neural Tumor Cells that Lack Trophic Support Mol. Cancer Res., January 1, 2007; 5(1): 47 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bogoyevitch and B. Kobe Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1061 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Chiara, M. E. Marcocci, M. Torcia, M. Lucibello, P. Rosini, P. Bonini, Y. Higashimoto, G. Damonte, A. Armirotti, S. Amodei, et al. Bcl-2 Phosphorylation by p38 MAPK: IDENTIFICATION OF TARGET SITES AND BIOLOGIC CONSEQUENCES J. Biol. Chem., July 28, 2006; 281(30): 21353 - 21361. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Malhi, S. F. Bronk, N. W. Werneburg, and G. J. Gores Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis J. Biol. Chem., April  |